Development of achn-490 for the treatment of lung infection caused by MDR acinetobacter baumannii and other pathogens R & D effort.

Ended Definitive Contract Awarded Last action

Contract number
HDTRA110C0086
Awardee
Awarding agency
Obligated
$1,938,142

Award facts

Contract value 100% obligated
$1,938,142.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Full and Open Competition · 3 offers Basic Research
Pricing
Cost No Fee
Place of performance
South San Francisco, CA 94080, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Other Administrative Action P00002 -$0
Other Administrative Action P00001 · Base period $0
Original award $1,938,142

About this award

This is a $1,938,142.00 cost-no-fee definitive contract awarded by the Defense Threat Reduction Agency (DTRA), a defense agency, to Achaogen, Inc., a for-profit organization, for the development of ACHN-490 to treat lung infections caused by multidrug-resistant Acinetobacter baumannii and other pathogens. The contract has a period of performance ending on July 29, 2011 and was initially awarded on July 30, 2010. This contract does not have a set-aside designation.

Quick answers

Who was awarded contract HDTRA110C0086?

HDTRA110C0086 was awarded to Achaogen, Inc. by Defense Threat Reduction Agency (Department of Defense) on July 30, 2010.

How much is contract HDTRA110C0086 worth?

The government has obligated $1,938,142 on HDTRA110C0086. Its current value, with exercised options, is $1,938,142.

Was contract HDTRA110C0086 competed?

The extent of competition for HDTRA110C0086 was full and open competition. The government received 3 offers.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award